Nikhil Prasad Fact checked by:Thailand Medical News Team Nov 11, 2024 3 days, 14 minutes ago
Medical News: The mpox virus (MPXV), once known primarily as a rare zoonotic disease, has surged in global attention and public health concern since the outbreak in 2022. Previously contained within certain African regions, the virus has now crossed continents, infecting thousands globally. This surge led to the declaration of mpox as a public health emergency, emphasizing the virus’s potential to cause significant health crises.
Innovative Approaches to Tackle Mpox Virus's Unique Immune Evasion Strategies
The virus belongs to the Orthopoxvirus genus, known for causing diseases like smallpox. However, unlike other poxviruses, mpox has developed unique methods to bypass the human immune system, complicating treatment and prevention efforts. This
Medical News report delves into the mechanisms that mpox employs to evade immune defenses and highlights innovative research aiming to develop effective vaccines and immunotherapies against the virus.
The Challenge of Immune Evasion
MPXV's intricate evolution has equipped it with sophisticated strategies to evade human immunity. Researchers from the Department of Health Sciences, National Natural Science Foundation of China, and Beijing Key Laboratory for HIV/AIDS Research have been studying how MPXV interacts with both innate and adaptive immunity. These studies reveal that MPXV's immune evasion tactics are more advanced than many other viruses, raising new challenges for treatment, especially in populations who haven’t received smallpox vaccinations.
MPXV’s genome encodes various proteins that manipulate human immune cells, particularly monocytes, granulocytes, and natural killer cells, allowing the virus to spread while staying undetected by immune defenses. Two notable proteins, caspase-1 inhibitors and a PKR escape-related protein, are central to mpox's immune evasion. These proteins suppress immune activation, which would typically help clear out viral infections, by inhibiting vital immune functions. Understanding how these proteins work has become essential for designing new therapeutic strategies.
Key Findings on Mpox Virus’s Immune Evasion
Researchers have discovered that MPXV specifically targets immune system pathways to prevent the body from recognizing and attacking the virus. Unlike most viruses that replicate quickly to overwhelm the immune system, MPXV uses "stealth" tactics:
-Blocking DNA Sensors: DNA sensors within human cells detect viral DNA and trigger immune responses. MPXV blocks these sensors, preventing an effective immune response. This is achieved by proteins that mimic human immune signaling molecules, disrupting pathways like the cGAS-STING pathway, which is crucial for detecting viral DNA.
-Neutralizing Natural Killer Cells: Natural killer (NK) cells play a vital role in early immunity, attacking infected cells. MPXV interferes with NK cell function by suppressing their activation. This prevent
s the immune system from responding to the virus, allowing MPXV to spread undetected.
-Manipulating T Cells: T cells are crucial for long-term immunity. MPXV hinders their activation, making it difficult for the body to build immunity against the virus. By disrupting T-cell receptors (TCRs), MPXV minimizes immune cell responses, enabling prolonged infection.
-Avoiding Antibody Neutralization: MPXV's viral envelope is resistant to neutralizing antibodies, which typically help contain viral infections. The virus uses host cell proteins on its surface to shield itself, making antibody responses less effective.
-Subverting the Complement System: The complement system enhances immune responses by marking pathogens for destruction. MPXV, particularly the Congo Basin strain, produces proteins that prevent complement activation, rendering immune cells ineffective at clearing the virus.
Implications for Vaccine Development
The virus's immune evasion mechanisms make developing effective vaccines challenging. Traditional vaccines rely on immune memory from antibodies and T-cell responses, but MPXV’s unique characteristics disrupt these responses. Researchers are therefore exploring alternative vaccine approaches, such as multi-epitope vaccines that target various parts of the virus, potentially outsmarting MPXV’s immune evasion strategies.
One promising approach involves nucleic acid-based vaccines, such as mRNA vaccines, which can be designed to specifically target MPXV’s evasion proteins. Animal studies have shown encouraging results, where vaccines targeting MPXV's specific proteins offered protective immunity.
Innovative Therapeutic Approaches
Beyond vaccines, researchers are considering novel therapies that could directly counter MPXV's immune evasion tactics. For instance, targeting the pathways blocked by MPXV proteins could help restore immune function. Therapies that activate the cGAS-STING pathway, for example, could counter the virus’s suppression of DNA sensors. Similarly, treatments that boost NK cell responses might prevent MPXV from spreading unchecked.
In immunosuppressed individuals, such as HIV patients, MPXV poses an even higher risk due to already weakened immune defenses. Current studies suggest that HIV-infected individuals experience more severe mpox symptoms, with higher risks of systemic infection. Therapeutic strategies that strengthen NK cell and T-cell responses could be especially valuable for these high-risk populations.
Conclusion
The mpox virus presents a complex challenge to public health, owing to its unique ability to evade immune detection. The virus’s tactics, such as suppressing DNA sensing, neutralizing NK cells, and avoiding antibody responses, allow it to spread while escaping immune clearance. These findings underscore the importance of tailored vaccines and therapies that address the specific immune evasion methods used by MPXV.
The future of mpox prevention lies in vaccines that can bypass the virus's defenses and therapies that restore normal immune function. Although MPXV shares some immune evasion strategies with other poxviruses, its unique adaptations demand new approaches to treatment and prevention. Advanced research on protein-based and nucleic acid vaccines offers hope for effective mpox vaccines, while therapies targeting immune pathways affected by MPXV proteins could provide critical support in managing infections.
The study findings were published in the peer-reviewed journal: Virologica Sinica.
https://www.sciencedirect.com/science/article/pii/S1995820X24001354
For the latest Mpox News, keep on logging on to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/new-targeted-therapy-shows-promise-against-mpox-monkeypox-virus-through-enhanced-immune-response
https://www.thailandmedical.news/news/gene-discoveries-shed-light-on-mpox-virus-and-digestive-issues
https://www.thailandmedical.news/articles/monkeypox